Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells

Neutral sphingomyelinase is known to be implicated in growth arrest, differentiation, proliferation, and apoptosis. Although previous studies have reported the involvement of neutral sphingomyelinase in hippocampus physiopathology, its behavior in the hippocampus during Parkinson's disease remains undetected. In this study, we show an upregulation of inducible nitric oxide synthase and a downregulation of neutral sphingomyelinase in the hippocampus of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- (MPTP-) induced mouse model of Parkinson's disease. Moreover, the stimulation of neutral sphingomyelinase activity with vitamin 1,25-dihydroxyvitamin D3 reduces specifically saturated fatty acid sphingomyelin by making sphingomyelin a less rigid molecule that might influence neurite plasticity. The possible biological relevance of the increase of neutral sphingomyelinase in Parkinson's disease is discussed.

[1]  D. Munoz,et al.  Cytomegalovirus in the human dentate gyrus and its impact on neural progenitor cells: report of two cases. , 2017, Clinical Neuropathology.

[2]  A. Klegeris,et al.  Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer's and Parkinson's Diseases. , 2017, Current aging science.

[3]  O. Manzoni,et al.  Amplification of mGlu5-Endocannabinoid Signaling Rescues Behavioral and Synaptic Deficits in a Mouse Model of Adolescent and Adult Dietary Polyunsaturated Fatty Acid Imbalance , 2017, The Journal of Neuroscience.

[4]  H. Reichmann,et al.  Accelerated Age-Dependent Hippocampal Volume Loss in Parkinson Disease With Mild Cognitive Impairment , 2017, American journal of Alzheimer's disease and other dementias.

[5]  L. Joseph,et al.  Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis. , 2017, Chemico-biological interactions.

[6]  P. Adlard,et al.  Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion , 2017, Scientific Reports.

[7]  C. Scherzer,et al.  Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice , 2017, Molecular Neurodegeneration.

[8]  L. Riboni,et al.  Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids , 2017, Advances in Therapy.

[9]  M. Garcia-Gil,et al.  Nuclear Lipids in the Nervous System: What they do in Health and Disease , 2016, Neurochemical Research.

[10]  J. Kornhuber,et al.  Regulation of Neuronal Stem Cell Proliferation in the Hippocampus by Endothelial Ceramide , 2016, Cellular Physiology and Biochemistry.

[11]  C. Bonhomme,et al.  Dairy fat blend improves brain DHA and neuroplasticity and regulates corticosterone in mice. , 2016, Prostaglandins, leukotrienes, and essential fatty acids.

[12]  H. Car,et al.  Regulation of sphingomyelin metabolism , 2016, Pharmacological reports : PR.

[13]  T. Beccari,et al.  e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease , 2016, Mediators of inflammation.

[14]  C. Scavone,et al.  Ouabain Modulates the Lipid Composition of Hippocampal Plasma Membranes from Rats with LPS-induced Neuroinflammation , 2015, The Journal of Membrane Biology.

[15]  T. Beccari,et al.  Very-long-chain fatty acid sphingomyelin in nuclear lipid microdomains of hepatocytes and hepatoma cells: can the exchange from C24:0 to C16:0 affect signal proteins and vitamin D receptor? , 2015, Molecular biology of the cell.

[16]  M. Garcia-Gil,et al.  Serum deprivation alters lipid profile in HN9.10e embryonic hippocampal cells , 2015, Neuroscience Letters.

[17]  J. Suckling,et al.  Multimodal MRI of the hippocampus in Parkinson’s disease with visual hallucinations , 2014, Brain Structure and Function.

[18]  T. Beccari,et al.  Analysis of Serum Sphingomyelin Species by Uflc-Ms/Ms in Patients Affected with Monoclonal Gammopathy , 2014 .

[19]  L. Parnetti,et al.  Lysosomal enzymes in PD: Further evidence is needed , 2014, Movement disorders : official journal of the Movement Disorder Society.

[20]  N. Babenko,et al.  Long-term food restriction prevents aging-associated sphingolipid turnover dysregulation in the brain. , 2014, Archives of gerontology and geriatrics.

[21]  W. Shen,et al.  Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi , 2013, Journal of Neuroinflammation.

[22]  E. Clementi,et al.  Sphingolipids and Brain Resident Macrophages in Neuroinflammation: An Emerging Aspect of Nervous System Pathology , 2013, Clinical & developmental immunology.

[23]  F. Curcio,et al.  Nuclear Lipid Microdomain as Place of Interaction between Sphingomyelin and DNA during Liver Regeneration , 2013, International journal of molecular sciences.

[24]  A. Chattopadhyay,et al.  Removal of sphingomyelin headgroup inhibits the ligand binding function of hippocampal serotonin1A receptors. , 2012, Biochemical and biophysical research communications.

[25]  G. Massicotte,et al.  Sphingomyelinase selectively reduces M1 muscarinic receptors in rat hippocampal membranes , 2012, Hippocampus.

[26]  F. Marini,et al.  Nuclear lipid microdomains regulate nuclear vitamin D3 uptake and influence embryonic hippocampal cell differentiation , 2011, Molecular biology of the cell.

[27]  Y. Hannun,et al.  Many Ceramides* , 2011, The Journal of Biological Chemistry.

[28]  M. Mattson,et al.  Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine‐1‐phosphate mediated mechanisms , 2010, Journal of neurochemistry.

[29]  M. V. Magni,et al.  Effect of 1α,25‐dihydroxyvitamin D3 in embryonic hippocampal cells , 2009, Hippocampus.

[30]  E. Albi,et al.  The nuclear ceramide/diacylglycerol balance depends on the physiological state of thyroid cells and changes during UV-C radiation-induced apoptosis. , 2008, Archives of biochemistry and biophysics.

[31]  E. Albi,et al.  Phosphatidylcholine/sphingomyelin metabolism crosstalk inside the nucleus. , 2008, The Biochemical journal.

[32]  R. Donato,et al.  Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles , 2002, Neuroscience.

[33]  Y. Hannun,et al.  Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. , 1989, The Journal of biological chemistry.

[34]  W. Hager,et al.  and s , 2019, Shallow Water Hydraulics.

[35]  R. Belli,et al.  Sphingomyelin Turnover Induced by Vitamin D 3 in HL-60 Cells , 2001 .